OralID gets a perfect score of +++++ with a 36 independent dentist review!
First Oral Cancer Screening Device ever to do so in Dentistry
By: Forward Science Technologies LLC
The Dental Advisor, a respected dental review company focusing on reviewing products based on clinical research, recently released the results of a 36 independent clinician, three-month review of OralID and CytID. The results for the OralID were the highest recorded in the oral cancer screening category, receiving a perfect 5 plus rating, 96% Clinical Rating, and an Editor’s Choice Award.
“We are very pleased, yet not surprised, with the results of their three month evaluation. The comments from the evaluators are what we consistently hear every day from our customers. This is why we have seen most of our current customers come from word of mouth referrals.” stated Luis Rivera, VP of Sales of Forward Science Technologies.
A science based clinical evaluation is one of the most important feedback mechanisms you can receive from a user. The Dental Advisor reviewed the OralID on its effectiveness, ease of use, simplicity, ergonomics, visualization in the mouth, and patient acceptance during the three month trial. “Working with an independent and science based organization is reassuring for a company like ours that was founded with a heavy focus on scientific justification for the technology,”
To find the results of the findings, go to: http://www.dentaladvisor.com/
ABOUT Forward Science Technologies LLC
Forward Science Technologies LLC is a privately held medical device company based in Houston, Texas. With the launch of CytID, Forward Science Technologies becomes the first company in the United States to provide an oral health protocol. In addition to being the only FDA Cleared oral cancer screening device with no per patient costs, OralID carries a sector leading 2-year warranty.